Clinical Trial of Growth Hormone in MPS I, II, and VI
Status:
Terminated
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether growth hormone is a safe and effective
treatment for short stature in children with Mucopolysaccharidosis type I, II, and VI.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Los Angeles Biomedical Research Institute Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center